Latest Capital Raising News

Zenith Minerals has launched a significant reverse circulation drilling program at its Red Mountain Gold Project, revealing visible gold at depth and confirming a large, continuous gold system. The company is well-funded to accelerate exploration and aims to expand the mineralised footprint rapidly.

Black Canyon Limited reported a robust cash position of A$11.6 million at the end of September 2025, supported by a strong equity raise that extends its funding runway to nearly three years.

Black Canyon Limited reports robust September quarter progress at its Wandanya manganese and iron project, revealing extensive high-grade mineralisation and securing $10 million to accelerate development.

Alicanto Minerals has raised approximately $3 million through a share placement to fund exploration at its Falun and Sala projects in Sweden and to pursue potential acquisitions.

Infini Resources has raised approximately A$12 million through a premium-priced Flow-Through Share placement and a concurrent share placement, fueling expanded uranium drilling programs across key Canadian projects.

Spectur Limited has successfully raised $2.3 million through a premium-priced placement to fast-track its AI Cloud Platform and sovereign cloud capabilities, alongside notable board changes ahead of its AGM.

Theta Gold Mines has mobilised contractors and begun civil works at its TGME Gold Mine Project, advancing steadily toward plant commissioning by the end of 2026 and production in early 2027.

Avecho Biotechnology has raised $2.5 million from institutional investors to fast-track manufacturing and regulatory preparations for its CBD TPM capsule amid ongoing Phase III trials.

Tivan Limited has made significant strides in its critical minerals portfolio, establishing a key joint venture, acquiring the Molyhil Project, raising $15 million, and commencing drilling at Sandover. These developments underscore its growing role in Australia’s strategic minerals sector.

Barton Gold Holdings Limited has launched a $2.5 million Share Purchase Plan alongside a $15 million placement, offering eligible shareholders a chance to invest at $1.25 per share to support critical project development.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Amaero Ltd reports a remarkable 445% increase in quarterly revenue driven by powder sales and manufacturing scale-up, alongside securing a US$22.8 million loan and exclusive supply agreements with key defense and aerospace players.